Ameriprise Financial Inc Emergent Bio Solutions Inc. Transaction History

Ameriprise Financial Inc

$375 Billion
Q4 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.5 - $3.41 $627,295 - $1.43 Million	-418,197 Reduced 97.39%	11,227 $28,000
Q4 2023 Feb 14, 2024	SELL	$1.82 - $3.16 $24,560 - $42,644	-13,495 Reduced 3.05%	429,424 $1.03 Million
Q3 2023 Nov 14, 2023	SELL	$3.17 - $7.91 $5,211 - $13,004	-1,644 Reduced 0.37%	442,919 $1.51 Million
Q2 2023 Aug 14, 2023	BUY	$7.35 - $13.21 $552,580 - $993,141	75,181 Added 20.35%	444,563 $3.27 Million
Q1 2023 May 15, 2023	SELL	$7.79 - $16.29 $936,903 - $1.96 Million	-120,270 Reduced 24.56%	369,382 $3.83 Million
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $493,295 - $961,925	44,845 Added 10.08%	489,652 $5.78 Million
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $1.5 Million - $2.68 Million	74,770 Added 20.21%	444,807 $9.34 Million
Q2 2022 Aug 15, 2022	BUY	$27.42 - $43.63 $161,202 - $256,500	5,879 Added 1.61%	370,037 $11.5 Million
Q1 2022 May 16, 2022	SELL	$36.48 - $52.22 $291,219 - $416,872	-7,983 Reduced 2.15%	364,158 $15 Million
Q4 2021 Feb 14, 2022	BUY	$33.11 - $55.01 $8.48 Million - $14.1 Million	256,015 Added 220.46%	372,141 $16.2 Million
Q3 2021 Nov 15, 2021	BUY	$50.07 - $66.05 $816,541 - $1.08 Million	16,308 Added 16.34%	116,126 $5.82 Million
Q2 2021 Aug 16, 2021	BUY	$56.61 - $80.46 $461,880 - $656,473	8,159 Added 8.9%	99,818 $6.29 Million
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $377,946 - $548,707	-4,383 Reduced 4.56%	91,659 $8.52 Million
Q4 2020 Feb 12, 2021	SELL	$79.17 - $111.47 $1.71 Million - $2.41 Million	-21,592 Reduced 18.36%	96,042 $8.61 Million
Q3 2020 Nov 16, 2020	SELL	$81.91 - $134.94 $10.7 Million - $17.7 Million	-131,166 Reduced 52.72%	117,634 $12.2 Million
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $1.7 Million - $2.8 Million	-31,322 Reduced 11.18%	248,800 $19.7 Million
Q1 2020 May 15, 2020	BUY	$49.34 - $68.76 $387,565 - $540,109	7,855 Added 2.89%	280,122 $16.2 Million
Q4 2019 Feb 14, 2020	SELL	$51.21 - $59.06 $350,993 - $404,797	-6,854 Reduced 2.46%	272,267 $14.7 Million
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $518,665 - $730,730	-12,775 Reduced 4.38%	279,121 $14.6 Million
Q2 2019 Aug 14, 2019	SELL	$39.92 - $53.86 $2.71 Million - $3.65 Million	-67,847 Reduced 18.86%	291,896 $14.1 Million
Q1 2019 May 15, 2019	SELL	$48.23 - $66.16 $1.33 Million - $1.82 Million	-27,545 Reduced 7.11%	359,743 $18.2 Million
Q4 2018 Feb 14, 2019	BUY	$55.63 - $73.24 $1.31 Million - $1.73 Million	23,590 Added 6.49%	387,288 $23 Million
Q3 2018 Nov 14, 2018	BUY	$52.05 - $66.51 $4.83 Million - $6.17 Million	92,821 Added 34.27%	363,698 $23.9 Million
Q2 2018 Aug 14, 2018	SELL	$48.33 - $55.64 $512,684 - $590,229	-10,608 Reduced 3.77%	270,877 $13.7 Million
Q1 2018 May 15, 2018	BUY	$44.44 - $54.39 $46,750 - $57,218	1,052 Added 0.38%	281,485 $14.8 Million
Q4 2017 Feb 12, 2018	BUY	$37.77 - $47.75 $89,665 - $113,358	2,374 Added 0.85%	280,433 $13 Million
Q3 2017 Nov 07, 2017	BUY	$34.14 - $40.45 $9.49 Million - $11.2 Million	278,059	278,059 $11.2 Million

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account